Skip to main content

$0.125 (0.00%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
25 May 2025 at 8:54pm
Register to track EMD and receive email alerts.

Emyria Obtains TGA Approval for Medical Grade Monitoring App

StockBot

416,823 posts

EMD released this announcement to the ASX on 12 May 2021, 11:24. The announcement is marked as price sensitive, and is 4 page(s) in length and 439.83kb in size.

You can view all announcements from EMD and see how they appear on a price chart on the announcements page.

At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 600th as of the latest reported data (17 April 2025).

Other Recent Announcements from EMD
Trading Halt 29 June 2023, 9:33
Emyria Receives Ethics Approval for MDMA-assisted Therapy 8 June 2023, 9:10
Section 708A(5)(e) Notice 10 May 2023, 18:37
Emyria Obtains TGA Approval for Medical Grade Monitoring App 12 May 2021, 11:24
Trading Halt 11 May 2021, 9:45
Emyria and MMA launch MDMA-assisted therapy program for PTSD 5 May 2021, 9:20
Appendix 2A and Notice Under Section 708A 28 April 2021, 18:07
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track EMD and receive email alerts.